Focused on Your Health

​

Founded in 2010, Althera develops innovative patient focused medicines.

​

Althera’s Rosuvastatin/Ezetimibe tablets is already approved and available to patients in more than 28 countries worldwide including United States and all major European markets.

​

US Healthcare Professionals can learn more about Roszet® at www.roszet.com. Please read full Prescribing information at roszet.com/pi.

​

Althera’s second product Ezetimibe/Atorvastatin tablets (AL-310), is approved in both US and Europe, and is expected to be available to patients next year.